Colorectal cancer is also known as colon or rectal cancer, develops in the colon and rectum, parts of the large intestine. It is the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide.

Common symptoms may include change in bowel habits, bloody stools, fatigue, or unexplained weight loss. When caught in its early stages, this cancer is highly treatable. It is vital to do regular screenings for early diagnosis and better survival outcomes. This early detection makes a significant difference in survival rates. 

Survival rates help to understand what percentage of people with colorectal cancers are likely to survive for a certain period after diagnosis. The survival rate numbers are based on data from patients large group and also help treatment decisions and expectations. 

Note: The survival rates are only estimates that are based on previous outcomes of people who had similar cancer, but there is no confirmation of what will happen in any specific person’s case. Every case is unique and every need is different.  

5-year Survival Rate of Colorectal Cancer

The 5-year survival rate of colorectal cancer refers to the percentage who are alive five years after being diagnosed with it. It is vital to understand that it doesn’t mean that the person only lives five years because it will differ in every case, but it is a standard way to understand the outcomes.

As per American Cancer Society data, the overall 5-year survival rate for colorectal cancer is about 65%. It means 65 patients out of 100 are likely to live at least 5 years after the diagnosis. This rate can vary depending on various factors such as the stage of cancer, age, and the patient’s overall health.

Survival Rates by Stage

The survival rate depends on how far the cancer has spread:

Stage 1 (Localized)

The survival rate at this stage is around 91% and the cancer hasn’t spread to lymph nodes or other organs. It is the early stage, which is mostly treatable, and surgery can remove the tumor that resulting in complete recovery. Most patients in this stage have an excellent prognosis, especially if the cancer is detected through colonoscopy.

Stage 2 and 3 (Regional)

The survival rate at this stage is around 70% and the cancer has spread to nearby lymph nodes but not to distant organs. Standard treatment includes surgery with chemotherapy and radiation therapy. The survival rate is lower than that of the localized stage, but still, many patients respond well to the treatment with positive outcomes.

Stage 4 (Distant)

This stage is crucial, and the survival rate is only about 15%. The cancer has spread to distant parts of the body such as the liver, lungs, or other organs. Due to its spread to other parts of the body, it becomes hard to treat. But, patients may still experience an extended survival rate in some cases where limited tumors are surgically removed and managed with targeted therapy.

Note: These survival rates are based on the stage at which the cancer is first diagnosed. They don’t reflect changes in prognosis if the cancer progresses, spreads further, or returns after initial treatment.